Natalia Kunst

• Heath, Anna; Kunst, Natalia; Jackson, Christopher; Strong, Mark; Alarid-Escudero, Fernando; Goldhaber-Fiebert, Jeremy D.; Baio, Gianluca; Menzies, Nicolas & Jalal, Hawre (2020). Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies. Medical decision making.  ISSN 0272-989X. . doi: 10.1177/0272989X20912402
• Kim, David D.; Silver, Madison C.; Kunst, Natalia; Cohen, Joshua T.; Ollendorf, Daniel A. & Neumann, Peter J. (2020). Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018. PharmacoEconomics (Auckland).  ISSN 1170-7690. . doi: 10.1007/s40273-020-00942-2
• Kunst, Natalia; Alarid-Escudero, Fernando; Aas, Eline; Coupe, Veerle; Schrag, Deborah & Kuntz, Karen (2020). Estimating Population-Based Recurrence Rates of Colorectal Cancer over Time in the United States. Cancer Epidemiology, Biomarkers and Prevention.  ISSN 1055-9965. . doi: 10.1158/1055-9965.EPI-20-0490
• Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly; Richman, Ilana & Gross, Cary (2020). Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine.  ISSN 2168-6106. . doi: 10.1001/jamainternmed.2020.0262
• Kunst, Natalia; Wang, Shi-Yi; Hood, Annette; Mougalian, Sarah; DiGiovanna, Michael; Adelson, Kerin & Pusztai, Lajos (2020). Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2(HER2)–Positive Breast Cancer. JAMA Network Open.  ISSN 2574-3805. . doi: 10.1001/jamanetworkopen.2020.27074
• Kunst, Natalia; Wilson, Edward C.F.; Glynn, David; Alarid-Escudero, Fernando; Baio, Gianluca; Brennan, Alan; Fairley, Michael; Goldhaber-Fiebert, Jeremy D.; Jackson, Chris; Jalal, Hawre; Menzies, Nicolas; Strong, Mark; Thom, Howard & Heath, Anna (2020). Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods. Value in Health.  ISSN 1098-3015.  23(6), s 734- 742 . doi: 10.1016/j.jval.2020.02.010
• Kunst, Natalia R.; Alarid-Escudero, Fernando; Paltiel, A. David & Wang, Shi-Yi (2019). A value of information analysis of research on the 21-gene assay for breast cancer management. Value in Health.  ISSN 1098-3015.  22(10), s 1102- 1110 . doi: 10.1016/j.jval.2019.05.004
• Kunst, Natalia R.; Lindvik, Helene; Carlsen, Kai-Håkon; Håland, Geir; Jørgensen, Eivind & Carlsen, Karin C. Lødrup (2019). Cost-effectiveness of diagnostic algorithms for peanut allergy in children. Journal of Allergy and Clinical Immunology.  ISSN 0091-6749.  143(3), s 1243- 1246 . doi: 10.1016/j.jaci.2018.10.050

Se alle arbeider i Cristin

• Byrne, Jennifer & Kunst, Natalia (2020, 27. mai). Mammography for women aged 40 to 49 years associated with high, widely variable costs. [Internett].  Healio.
• Dunleavy, Brian P. & Kunst, Natalia (2020, 23. mars). Less than half of women in their 40s screened for breast cancer each year. [Internett].  United Press International.
• Kunst, Natalia (2020). Quantifying the value of further research to improve 21-gene assay decision-making in breast cancer.
• Kunst, Natalia (2020). Value of Information analysis in medical decision making.
• Kunst, Natalia & Gross, Cary (2020). Breast Cancer Screening and Health Care Costs—Reply. JAMA Internal Medicine.  ISSN 2168-6106. . doi: 10.1001/jamainternmed.2020.2355
• Kunst, Natalia & Mamoun, Fred (2020, 23. mars). Breast Cancer Screening Costs High, Benefits Uncertain, for Women in 40s. [Internett].  Yale News.
• Furlow, Bryant & Kunst, Natalia (2019, 14. oktober). All Women with Breast Cancer Should Undergo Multigene Testing, Study Suggests. [Tidsskrift].  Cancer Network.
• Kunst, Natalia (2019). Diagnosing peanut allergy in children: A cost-effectiveness analysis of diagnostic algorithms..
• Kunst, Natalia (2019). Finding the optimal diagnostic algorithm for children with peanut allergy: A cost-effectiveness study.
• Kunst, Natalia R. (2019). A comprehensive value of information analysis to assess the state of the evidence and quantify uncertainty on the use of 21-gene assay Oncotype DX.
• Kunst, Natalia; Alarid-Escudero, Fernando; Aas, Eline; Coupe, Veerle & Kuntz, Karen (2019). Real-World Recurrence Rates of Colorectal Cancer over Time.
• Kunst, Natalia; Grosse, Scott; Chen, Yao-Hsuan; Kim, David & Wisløff, Torbjørn (2019). Overview of various recommendations for health economic perspective. Symposium: Value for whom? Choice and Consequences of Perspective in Economic Evaluations..
• Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly; Richman, Ilana & Gross, Cary (2019). Utilization and costs of breast cancer screening for women in their 40s in a privately insured US population.
• Kunst, Natalia; Wang, Shi-Yi; Hood, Annette; Mougalian, Sarah; DiGiovanna, Michael; Adelson, Kerin & Pusztai, Lajos (2019). Cost-effectiveness of different neoadjuvant followed by adjuvant treatment strategies for women with HER2-positive breast cancer (Spotlight Session).
• Kunst, Natalia; Wilson, Ed; Alarid-Escudero, Fernando; Baio, Gianluca; Brennan, Alan; Fairley, Michael; Glynn, David; Goldhaber-Fiebert, Jeremy; Jackson, Chris; Jalal, Hawre; Menzies, Nicolas; Strong, Mark; Thom, Howard & Heath, Anna (2019). Practical Considerations for the Efficient Computation of the Expected Value of Sample Information to Prioritize Research in Health Care.
• Kunst, Natalia R. (2018). Future research on the 21-gene assay for breast cancer: A value of information analysis.
• Kunst, Natalia R. (2018). What is the value of further research on the 21-gene assay for breast cancer management?.
• Kunst, Natalia R.; Alarid-Escudero, Fernando & Wang, Shi-Yi (2018). Decisions on Further Research for 21-Gene Assay in Real-World Management of Breast Cancer: A Value of Information Analysis. [Lee B. Lusted Award Finalist].
• Kunst, Natalia R.; Lindvik, Helene; Carlsen, Kai-Håkon; Håland, Geir; Jørgensen, Eivind & Carlsen, Karin C. Lødrup (2018). Diagnosing Peanut Allergy in Children: A Cost-Effectiveness Analysis of Diagnostic Algorithms.
• Kunst, Natalia R. (2017). Health economic modeling to determine the optimal diagnostic algorithm for nut allergy.

Se alle arbeider i Cristin